Online Enquiry
Subscribe
Log in / New User
Retrieve Password
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Log In
|
New User Registration
|
Retrieve Password
Log In
News
TheMarket
IndustryNews
RegulatoryNews
GeneralHealth
Legal/IPRNews
Product/R&DNews
API/BulkDrugNews
PeopleintheNews
OtherNews
TopNewsWorldwide
FEATURE ARTICLES
Editorials
FocusArticles
ExpertOpinions
Interviews
CaseStudies
CompanyProfiles
NewsinFocus
Editor'sPicks
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis...
China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)
China Private Biotech Financing Slows in Febru... (3/13/2026)
China's Labs Race for the Next First-in-Class ... (3/12/2026)
China Challenges High-Priced Gene Therapies wi... (3/10/2026)
China Biotech Dealmaking Defies Seasonal Slowd... (3/10/2026)
US Weighs Policy Measures to Address China Bio... (3/10/2026)
China Biotech Financing Rebounds in Early 2026... (3/9/2026)
China Biotech Outlicensing Surges Past US$52 B... (3/4/2026)
2026 Biotech Playbook: Hong Kong at the Centre... (3/2/2026)
China's Healthcare Reform Playbook: Boosting B... (2/26/2026)
China Outpaces US and EU in Drug R&D with Fast... (2/25/2026)
Global Pharma Giants Rush to License Chinese W... (2/25/2026)
The Patent Term Compensation and Protection Sc... (2/25/2026)
CMS Wins NMPA Approval for Desidustat Ta... (3/13/2026)
Veristat Expands Regulatory and Clinical... (3/13/2026)
Jeyou Pharma Raises About CNY 2B in Seri... (3/13/2026)
UniXell Secures FDA Clearance to Begin C... (3/13/2026)
Almirall Expands China Presence, Seeks M... (3/12/2026)
Pamplona and Coherent Partner on Targete... (3/12/2026)
Eli Radiopharma Raises ~CNY 100M to Adva... (3/12/2026)
Hansoh Launches Phase 3 Trial of B7-H3 A... (3/12/2026)
China Releases Trial Guideline for Influ... (3/11/2026)
China Issues Revised Technical Guideline... (3/11/2026)
China Seeks Comments on Draft Technical ... (3/11/2026)
Eli Lilly Plans $3B China Manufacturing ... (3/11/2026)
Peak Perform Innova Raises ~CNY 100M Ang... (3/11/2026)
Erasca Expands License With Joyo Pharmat... (3/11/2026)
Haleon Expands Oral-Health Presence in C... (3/10/2026)
Novo Nordisk and United Labs Report ~20%... (3/10/2026)
India Still Relies Heavily on China for ... (3/10/2026)
Ascletis Reports Positive Phase 2 Result... (3/10/2026)
China Pharmaceutical Market Projected to Reach US$573B ...
China's Vaccine Exports Jump More Than 50% in 2025 as O...
China's Vaccine Market Set for Slow but Steady Growth T...
China Companion Animal Health Market to Reach US$ 3.7B ...
China's Pet Obesity Sparks Biotech Race for Weight-Loss...
Jeyou Pharma Raises About CNY 2B in Series A to Advance...
Veristat Expands Regulatory and Clinical Trial Services...
Eli Radiopharma Raises ~CNY 100M to Advance Theranostic...
Pamplona and Coherent Partner on Targeted Protein Degra...
Almirall Expands China Presence, Seeks More Dermatology...
China Seeks Comments on Draft Technical Guideline for R...
China Issues Revised Technical Guideline for HPV Vaccin...
China Releases Trial Guideline for Influenza Vaccine Cl...
NMPA Seeks Input on Draft Guidelines for Quality Summar...
China Publishes 102nd Batch of Reference Formulations f...
China's Average Life Expectancy Hits 79.25 Years in 202...
China's Tech Giants Pour Billions Into AI Healthcare Am...
China-SCO Cooperation Center for Metabolic Diseases Lau...
China Accelerates Dementia Research to Challenge U.S. L...
China Expands Mutual Recognition of Medical Tests to St...
U.S. ITC to Probe China's Trade Status and Biotech Prac...
China Schedules Antitrust Hearing in Abuse‑of‑Dominan...
Pentagon Reverses Decision After Briefly Listing WuXi A...
China Indicts AstraZeneca and Former China Head Leon Wa...
Roche and Henlius–Organon Resolve U.S. Patent Dispute ...
India Still Relies Heavily on China for Essential Pharm...
Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See...
Abraham Accords Partners Could Help the U.S. Reduce Pha...
PhIIC Report Highlights China's API Industry Rebound as...
India and China Explore Reverse-Trade Model for Pharmac...
UniXell Secures FDA Clearance to Begin Clinical Testing...
CMS Wins NMPA Approval for Desidustat Tablets to Treat ...
Hansoh Launches Phase 3 Trial of B7-H3 ADC HS-20093 Wit...
Junshi Secures NMPA Acceptance for Subcutaneous Toripal...
Laekna and Eli Lilly Complete Phase 1 Study of ActRIIA ...
BioAtla and BeiGene Revise Global Deal for Novel Condit...
Pfizer to Absorb Mylan, Creating Global Generic Powerho...
PhRMA Calls for Trade Deals That Force Countries to Pay...
IQVIA: Global Pharma to Grow Slower in the Next Five Ye...
Pfizer and GSK Announce JV to Create a Global Consumer ...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Official and Executive Moves
Recent Executive Moves
China Introduces Plan for Pudong New Area's Pilot Compr...
Upcoming Event: 2023 Pharma CI USA Conference & Exhibit...
Upcoming Event: 15th Annual Pharma Market Research Conf...
Upcoming Event: 6th International Conference on Emergin...
Upcoming Event: PHARM Connect Congress
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
2023 Order Form + Product Descripti...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WiCON Publishes the China Pharmaceu...
WEEKLY e-ALERT(Premium)
WEEKLY e-ALERT(Basic)
GENERAL INFORMATION
TERMS/CONDITIONS OF USE
PRIVACY STATEMENT
JOIN THE MAILING LIST
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit